A 9 years expertise of QuailCRO, which is highly appreciated and is considered the best alternative to Romanian subsidiaries of full-services international CROs.

 

The specific population of patients needed in difficult clinical trials.
QuailCRO's position on the first 10 Romanian companies, submitting Phase II and Phase III studies, with 43 trials submitted and approved in the last 7 years.
Drug and Medical Devices clinical trials.
Reliable high-quality services, including drug development planning, strategic assessment, submission, dossier planning, executing and maintenance.
Our partners appreciation for our success in achieving the timelines assumed.

A team which is building strong relationship with regulatory bodies, hospital managers, medical opinion leaders and individuals involved in performance of clinical trials in Europe.